⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ly3022855

Every month we try and update this database with for ly3022855 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of LY3022855 In Participants With Breast or Prostate CancerNCT02265536
Neoplasms
Neoplasm Metast...
LY3022855
18 Years - Eli Lilly and Company
A Study of LY3022855 In Participants With Breast or Prostate CancerNCT02265536
Neoplasms
Neoplasm Metast...
LY3022855
18 Years - Eli Lilly and Company
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid TumorsNCT02718911
Solid Tumor
LY3022855
Durvalumab
Tremelimumab
18 Years - Eli Lilly and Company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: